These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39055849)

  • 1. Epidemiological and clinical characteristics of patients with carbapenem-resistant Enterobacterales in a university hospital of Colombia: Enzyme coproductions in rise.
    Contreras-Valero JF; Gualtero-Trujillo SM; Cortés-Fraile GC; Hernández-Garzón S; Manrique-Marín N; Narváez-Chaves MÁ; Valderrama-Beltrán SL
    Heliyon; 2024 Jul; 10(13):e33698. PubMed ID: 39055849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meropenem-Vaborbactam Activity against U.S. Multidrug-Resistant
    Shortridge D; Kantro V; Castanheira M
    Microbiol Spectr; 2023 Feb; 11(1):e0450722. PubMed ID: 36622238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical epidemiology of carbapenem-resistant Enterobacterales in the Greater Houston region of Texas: a 6-year trend and surveillance analysis.
    Tadese BK; Darkoh C; DeSantis SM; Mgbere O; Fujimoto K
    J Glob Antimicrob Resist; 2022 Sep; 30():222-227. PubMed ID: 35764216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant
    Huang YT; Kuo YW; Lee NY; Tien N; Liao CH; Teng LJ; Ko WC; Hsueh PR;
    Microbiol Spectr; 2022 Feb; 10(1):e0172821. PubMed ID: 35019772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Types of Carbapenemase and Clinical Outcomes of Infection Due to Carbapenem Resistance Enterobacterales.
    Pudpong K; Pattharachayakul S; Santimaleeworagun W; Nwabor OF; Laohaprertthisan V; Hortiwakul T; Charernmak B; Chusri S
    Infect Drug Resist; 2022; 15():3025-3037. PubMed ID: 35720254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors and Outcomes of Patients Colonized with KPC and NDM Carbapenemase-Producing Enterobacterales.
    Saidel-Odes L; Sagi O; Troib S; Leeman H; Nativ R; Schlaeffer-Yosef T; Azulay H; Nesher L; Borer A
    Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical outcomes of patients infected with KPC- and NDM-producing Enterobacterales: a retrospective cohort study.
    Seo H; Kim HJ; Kim MJ; Chong YP; Kim SH; Lee SO; Choi SH; Kim YS; Woo JH; Jung J
    Clin Microbiol Infect; 2021 Aug; 27(8):1167.e1-1167.e8. PubMed ID: 33010443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Immunochromatographic NG-Test Carba 5, RESIST-5 O.O.K.N.V., and IMP
    Han R; Guo Y; Peng M; Shi Q; Wu S; Yang Y; Zheng Y; Yin D; Hu F
    Front Microbiol; 2020; 11():609856. PubMed ID: 33519761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenemase investigation with rapid phenotypic test (RESIST-4 O.K.N.V) and comparison with PCR in carbapenem-resistant
    Yaşar-Duman M; Çilli F; Tekintaş Y; Polat F; Hoşgör-Limoncu M
    Iran J Microbiol; 2022 Jun; 14(3):328-333. PubMed ID: 37124854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbapenemase detection by NG-Test CARBA 5-a rapid immunochromatographic assay in carbapenem-resistant
    Zhu Y; Jia P; Li X; Wang T; Zhang J; Zhang G; Duan S; Kang W; Xu Y; Yang Q
    Ann Transl Med; 2021 May; 9(9):769. PubMed ID: 34268382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology of clinical isolation of carbapenem-resistant Enterobacterales and application of carbapenemase inhibitor enhancement test.
    Li H; Zhong Y; Yan Q; Liu W; Liang X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1210-1216. PubMed ID: 37875361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the NG-Test Carba 5, Colloidal Gold Immunoassay (CGI) Test, and Xpert Carba-R for the Rapid Detection of Carbapenemases in Carbapenemase-Producing Organisms.
    Gu D; Yan Z; Cai C; Li J; Zhang Y; Wu Y; Yang J; Huang Y; Zhang R; Wu Y
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016-2018.
    Paveenkittiporn W; Lyman M; Biedron C; Chea N; Bunthi C; Kolwaite A; Janejai N
    Antimicrob Resist Infect Control; 2021 Jun; 10(1):88. PubMed ID: 34090537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria.
    Hansen GT
    Infect Dis Ther; 2021 Mar; 10(1):75-92. PubMed ID: 33492641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Evaluation of Phenotypic Synergy Tests versus RESIST-4 O.K.N.V. and NG Test Carba 5 Lateral Flow Immunoassays for the Detection and Differentiation of Carbapenemases in
    Josa M D; Leal R; Rojas J; Torres M I; Cortés-Muñoz F; Esparza G; Reyes LF
    Microbiol Spectr; 2022 Feb; 10(1):e0108021. PubMed ID: 35107384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characteristics and evaluation of the phenotypic detection of carbapenemases among
    Liang B; Chen Y; Liang Z; Li X; Cai H; Lai H; Zhong H; Xie Y; Huang L; Gao F; Long Y
    Front Cell Infect Microbiol; 2024; 14():1357289. PubMed ID: 39027138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of
    Rada AM; De La Cadena E; Agudelo C; Capataz C; Orozco N; Pallares C; Dinh AQ; Panesso D; Ríos R; Diaz L; Correa A; Hanson BM; Villegas MV; Arias CA; Restrepo E
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32958711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible
    Kazmierczak KM; Karlowsky JA; de Jonge BLM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0200020. PubMed ID: 33972241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of intestinal colonization and nosocomial infection with carbapenem-resistant
    Pan F; Chen P; Duan Y; Yu F; Weng W; Zhang H
    Front Public Health; 2023; 11():1251609. PubMed ID: 38074706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid characterization of carbapenem-resistant Enterobacterales by multiplex lateral flow assay and detection of ceftazidime-avibactam-aztreonam synergy.
    Kalaivani R; Kali A; Surendran R; Sujaritha T; Ganesh Babu CP
    Indian J Med Microbiol; 2024; 47():100530. PubMed ID: 38246242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.